Up to 28 February 2021, the TGA has approved over 99,000 SAS Category B applications for unapproved medicinal cannabis products.
The approval numbers are up again over at the TGA.*
|Month||Number of SAS Category B approvals|
These figures represent the number of SAS Category B approvals only.
Important to remember that Approval under the SAS does not necessarily mean the patient has accessed or continues to access treatment. Following approval, the actual supply of medicinal cannabis is a matter for the medical practitioner, pharmacy and their patient.